While modulating JNK2 activity could be a promising approach to stopping Ca2+-triggered activity, and improving myocardial conduction and, consequently, eliminating AF in chronic alcohol users, further investigation is clearly warranted, to understand whether the inhibition of JNK2 would also allow the maintenance of abnormal cardiac function in long-term alcohol-exposed hearts. This evidence concerns the gene MAPK9 and atrial fibrillation.